Learn More
Description
Myristoleic acid induces apoptosis and necrosis in human prostate cancer LNCaP cells at a rate of 8.8% and 8.1%, respectively. It has a minimal inhibitory concentration (MIC) of 9μM in vivo.
Specifications
Specifications
| Refractive Index | n20/D 1.446 (Lit.) |
| Quantity | 500 mg |
| Formula Weight | 240.4 |
| Percent Purity | ≥99% |
| Physical Form | Liquid |
Safety and Handling
| Recommended Storage | −20°C |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.